Seungwon Kim

Seungwon Kim practices at UPMC Presbyterian in Pittsburgh, Pennsylvania, part of University of Pittsburgh Medical Center.

Seungwon Kim's NPI, 1114951019, was assigned on July 10, 2006. Seungwon Kim graduated from State University of NY Upstate Medical University in 1998. Seungwon Kim holds Pennsylvania license MD429200.

Seungwon Kim's primary practice is UPMC Presbyterian, at 200 Lothrop Street, Pittsburgh, PA 15213 in Allegheny County. The practice phone is (412) 647-2345.

Seungwon Kim's primary practice is UPMC Presbyterian in Pittsburgh, Pennsylvania, part of University of Pittsburgh Medical Center. Seungwon Kim is also affiliated with Select Specialty Hospital - Pittsburgh / UPMC. The medical group on file is University of Pittsburgh Physicians, Department of Radiology. Dmand AI also links Seungwon Kim to 5 more hospitals, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Seungwon Kim practices, 7 sites in all. Vendor and product names are available with a free account.

Otolaryngology is Seungwon Kim's primary specialty in the NPI Registry, under taxonomy code 207Y00000X. Seungwon Kim is licensed in Pennsylvania.

CMS data shows 662 Medicare services from Seungwon Kim across 10 procedure codes in 2024, for 276 Medicare patients. Medicare paid $86,198 for them.

CMS counts 276 Medicare patients who saw Seungwon Kim in 2024. The largest group is 65 to 74, with 162 patients. 72% of them have high cholesterol, and 70% have high blood pressure. 8% are also on Medicaid. Their average risk score is 1.50, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Seungwon Kim's median patient age at 71, with 43% women.

In 2024, Seungwon Kim wrote 252 Medicare Part D claims for 130 patients. 97% of them were for generic drugs. CMS names the drug for 187 of them, across 5 drugs with 11 or more claims each, at $1,918 in total drug cost. In 2023, CMS named 155 claims across 5 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 81 out of 100 for Seungwon Kim for performance year 2024, reported as part of a group. Seungwon Kim accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Seungwon Kim as offering telehealth.

Melanoma (skin cancer) excision: 1 to 10 procedures (CMS shows small counts as a range)

Skin biopsy: 1 to 10 procedures (CMS shows small counts as a range)

Upper gastrointestinal (GI) endoscopy for acid reflux: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 135 papers to Seungwon Kim, published from 2010 to 2025. 2017 was the busiest year, with 11. The most frequent topics are Head and Neck Neoplasms, Carcinoma, Squamous Cell and Squamous Cell Carcinoma of Head and Neck. Seungwon Kim has published most often in Head Neck. Seungwon Kim's most frequent co-authors are Robert Louis Ferris, MD, Mark W. Kubik and James P. Ohr, DO.

Dmand AI links Seungwon Kim to 1 clinical trial. Conditions studied include Hyperplasia and Carcinoma in Situ.

CMS Open Payments shows 9 general payments to Seungwon Kim from 2 drug and device companies from 2023 to 2025. Travel and lodging make up the largest share, 82% of the total. Medtronic, Inc. paid the most, $1,046.

Seungwon Kim graduated from State University of NY Upstate Medical University in 1998.